BioinvestGPT correctly predicted 5 of 6 major drug trials, Polymarket reports
AI startup BioinvestGPT forecasted the outcomes of five of six major drug trials before results were announced, according to Polymarket.
CODEX / SIGNAL STUDIO
CODEX / SIGNAL STUDIO
AI startup BioinvestGPT forecasted the outcomes of five of six major drug trials before results were announced, according to Polymarket.